Dr. Pavel Osmancik and I discuss: Catheter Ablation Vs. Risk Factor Modification With Antiarrhythmic Drugs To Treat Atrial Fibrillation – PRAGUE-25 Study March 30, 2025 2025 | ACC | Cardiology | Trial | Video Disclosures: TBD Article Navigation Dr. Giulia Magnani and I discuss: Alliance For Secondary Prevention After An Acute Coronary Syndrome. Dr. Steven E. Nissen and I discuss: An Extended Duration Small-interfering RNA Targeting Lipoprotein(a): The Alpaca Phase 2 Trial Of Lepodisiran With 540 Day Follow Up
